L-Dopa stimulates expression of the antioxidant enzyme NAD(P)H:quinone oxidoreductase (NQO) in cultured astroglial cells

Free Radical Biology and Medicine

Volumn 29, Issue 5, 2000, Pages 442-453

  Van Muiswinkel, Freek L ^a   Riemers, Frank M ^a   Peters, Godefridus J ^b   LaFleur, M Vincent M ^b   Siegel, David ^c   Jongenelen, Cornelis A M ^a   Drukarch, Benjamin ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Astrocytes; Free radicals; Glutathione; L Dopa; NAD(P)H:quinone oxidoreductase (NQO); Neuroprotection; Parkinson's disease; Quinones

Indexed keywords

GLUTATHIONE; HYDROQUINONE DERIVATIVE; LEVODOPA; MESSENGER RNA; OXIDOREDUCTASE; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL CELL; ARTICLE; ASTROCYTE; AUTOOXIDATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DETOXIFICATION; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; ENZYME REGULATION; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMAL; ANIMALS, NEWBORN; ASTROCYTES; ASTROCYTOMA; CELLS, CULTURED; DICUMAROL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INDOMETHACIN; LEVODOPA; NAD(P)H DEHYDROGENASE (QUINONE); POLYMERASE CHAIN REACTION; RATS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0034282212     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00328-2     Document Type: Article

References (58)

1. Han S.K., Mytilineou C., Cohen G. L-Dopa up-regulates glutathione and protects mesencephalic cultures against oxidative stress. J. Neurochem. 66:1996;501-510.
2. Mena M.A., Casarejos M.J., Carazo A., Paino C.L., De Yebenes J.G. Glia conditioned medium protects fetal dopaminergic neurones in culture from L-Dopa toxicity. Neuroreport. 7:1996;441-445.
3. Mena M.A., Casarejos M.J., Carazo A., Paino C.L., De Yebenes J.G. Glia protect fetal midbrain dopamine neurons in culture from L-Dopa toxicity through multiple mechanisms. J. Neural. Transm. 104:1997;317-328.
4. Agid Y. Levodopa, is toxicity a myth? Neurology. 50:1998;858-863.
5. Graham D.G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14:1978;633-643.
6. Bindoli A., Rigobello M.P., Deeble D.J. Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic. Biol. Med. 13:1992;391-405.
7. Langeveld C.H., Jongenelen C.A.M., Schepens E., Stoof J.C., Bast A., Drukarch B. Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal development. Neurosci. Lett. 192:1995;13-16.
8. Drukarch B., Schepens E., Jongenelen C.A.M., Stoof J.C., Langeveld C.H. Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency. Brain Res. 770:1997;123-130.
9. Drukarch B., Schepens E., Stoof J.C., Langeveld C.H., van Muiswinkel F.L. Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species. Free Radic. Biol. Med. 25:1998;217-220.
10. Raps S.P., Lai J.C.K., Hertz L., Cooper A.J.L. Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res. 493:1989;398-401.
11. Langeveld C.H., Schepens E., Jongenelen C.A.M., Stoof J.C., Hjelle O.P., Ottersen O.P., Drukarch B. Presence of glutathione immunoreactivity in cultured neurones and astrocytes. Neuroreport. 7:1996;1833-1836.
12. Mytilineou C., Han S.K., Cohen G. Toxic and protective effects of L-Dopa on mesencephalic cultures. J. Neurochem. 61:1993;1470-1478.
13. Cadenas E. Antioxidant and prooxidant functions of DT-Diaphorase in quinone metabolism. Biochem. Pharmacol. 49:1995;127-140.
14. Smythies J., Galzigna L. The oxidative metabolism of catecholamines in the brain a review . Biochim. Biophys. Acta. 1380:1998;159-162.
15. Lind C., Cadenas E., Hochstein P., Ernster L. DT-diaphorase purification, properties, and function . Methods Enzymol. 186:1990;287-301.
16. Schultzberg M., Segura-Aquilar J., Lind C. Distribution of DT diaphorase in the rat brain biochemical and immunohistochemical studies . Neuroscience. 27:1988;763-776.
17. Murphy T.H., So A.P., Vincent S.R. Histochemical detection of quinone reductase activity in situ using LY 83583 reduction and oxidation. J. Neurochem. 70:1998;2156-2164.
18. Ahlgren-Beckendorf J.A., Reising A.M., Schander M.A., Herdler J.W., Johnson J.A. Coordinate regulation of NAD(P)H:quinone oxidoreductase and glutathione-S-transferases in primary cultures of rat neurones and glia role of the antioxidant/electrophile responsive element . Glia. 25:1999;131-142.
19. Prochaska H.J., De Long M.J., Talalay P. On the mechanisms of induction of cancer-protective enzymes a unifying proposal . Proc. Natl. Acad. Sci. USA. 82:1985;8232-8236.
20. Prestera T., Holtzclaw D., Zhang Y., Talalay P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. USA. 90:1993;2965-2969.
21. Benda P., Lightbody J., Sato G., Levine L., Sweet W. Differential rat glial cell strain in tissue culture. Science. 161:1968;370-371.
22. Drukarch B., Jongenelen C.A.M., Schepens E., Langeveld C.H., Stoof J.C. Glutathione is involved in the granular storage of dopamine in rat PC12 pheochromocytoma cells implications for the pathogenesis of Parkinson's disease . J. Neurosci. 16:1996;6038-6045.
23. Gilliland G., Perrin S., Blanchard K., Bunn F.H. Analysis of cytokine mRNA and DNA detection and quantitation by competitive polymerase chain reaction . Proc. Natl. Acad. Sci. USA. 87:1990;2725-2729.
24. Raeymaekers L. Quantitative PCR theoretical considerations with practical implications . Anal. Biochem. 214:1993;582-585.
25. Wang W., Dow K.E. Quantitative analysis of mRNA expression of neuron-specific growth-associated genes in rat primary neurons by competitive RT-PCR. Brain Res. Brain Res. Protoc. 2:1998;199-208.
26. Bayney R.M., Morton M.R., Favreau L.V., Pickett C.B. Rat liver NAD(P)H:Quinone reductase. Regulation of quinone reductase gene expression by planar aromatic compounds and determination of the exon structure of the quinone reductase structural gene. J. Biol. Chem. 264:1989;21793-21797.
27. Nudel U., Zakut R., Shani M., Neuman S., Levy Z., Yaffe D. The nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucleic Acids Res. 11:1983;1759-1771.
28. Prochaska H.J., Santamaria A.B. Direct measurement of NAD(P)H:Quinone reductase from cells cultured in microtiter wells a screening assay for anticarcinogenic enzyme inducers . Anal. Biochem. 169:1988;328-336.
29. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
30. Chen S., Wu K., Zhang D., Sherman M., Knox R., Yang C.S. Molecular characterization of binding of substrates and inhibitors to DT-diaphorase combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling . Mol. Pharmacol. 56:1999;272-278.
31. Wermuth B. Purification and properties of an NADPH-dependent carbonyl reductase from human brain. J. Biol. Chem. 256:1981;1206-1213.
32. Misra V., Klamut H.J., Rauth A.M. Transfection of COS-1 cells with DT-diaphorase cDNA role of a base change at position 609 . Br. J. Cancer. 77:1998;1236-1240.
33. Siegel D., Franklin W.A., Ross D. Immunohistochemical detection of NADP(H)-:quinone oxidoreductase in human lung and lung tumors. Clin. Cancer Res. 4:1998;2065-2070.
34. Mena M.A., Pardo B., Casarejos M.J., Fahn S., De Yebenes J.G. Neurotoxicity of levodopa on catecholamine-rich neurons. Mov. Disord. 7:1992;23-31.
35. Wirth H., Wermuth B. Immunohistochemical localization of carbonyl reductase in human tissues. J. Histochem. Cytochem. 40:1992;1857-1863.
36. Zhong H., Simons J.W. Direct comparison of GAPDH, β-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem. Biophys. Res. Commun. 259:1999;523-526.
37. Mangoura D., Sakellaridis N., Jones J., Vernadakis A. Early and late passage C-6 glial cell growth similarities with primary glial cells in culture . Neurochem. Res. 14:1989;941-947.
38. Galloway D.C., Blake D.G., Shepherd A.G., McLellan L.I. Regulation of human gamma-glutamylcysteine synthetase co-ordinate induction of the catalytic and regulatory subunits in HepG2 cells . Biochem. J. 328:1997;99-104.
39. Jaiswal A.K. Antioxidant response element. Biochem. Pharmacol. 48:1994;439-444.
40. Meister A. On the antioxidant effects of ascorbic acid and glutathione. Biochem. Pharmacol. 44:1992;1905-1915.
41. Favreau L.V., Pickett C.B. The rat quinone reductase antioxidant reponse element. Identification of the nucleotide sequence required for basal and inducible activity and detection of antioxidant response element-binding proteins in hepatoma and non-hepatoma cell lines. J. Biol. Chem. 270:1995;24468-24474.
42. Li Y., Jaiswal A.K. Regulation of human NAD(P)H:quinone oxidoreductase gene. J. Biol. Chem. 267:1992;15097-15104.
43. Bergelson S., Pinkus R., Daniel V. Intracellular glutathione levels regulate Fos/Jun induction and activation of glutathione S-transferase gene expression. Cancer Res. 54:1994;36-40.
44. Mena M.A., Pardo B., Paino C.L., De Yebenes J.G. Levodopa toxicity in foetal rat midbrain neurones in culture modulation by ascorbic acid . Neuroreport. 4:1993;438-440.
45. Uitti R.J., Ahlskog J.E., Maraganore D.M., Muenter M.D., Atkinson E.J., Cha R.H., O'Brien P.C. Levodopa therapy and survival in idiopathic Parkinson's disease Olmsted county project . Neurology. 43:1993;1918-1926.
46. Gwinn-Hardy K., Evidente V.G.H., Waters C., Muenter M.D., Hardy J. L-Dopa slows the progression of familial parkinsonism. Lancet. 353:1999;1850-1851.
47. Hefti F., Melamed E., Bhawan J., Wurtman R.J. Long-term administration of L-Dopa does not damage dopaminergic neurons in the mouse. Neurology. 31:1981;1194-1195.
48. Murer M.G., Dziewczapolski G., Menalled L.B., Garcia M.C., Agid Y., Gershanik O., Raisman-Vozari R. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions. Ann. Neurol. 43:1998;561-575.
49. Tsacopoulos M., Magistretti P.J. Metabolic coupling between glia and neurons. J. Neurosci. 16:1996;877-885.
50. Desagher S., Glowinsky J., Premont J. Astrocytes protect neurons from hydrogen peroxide toxicity. J. Neurosci. 16:1996;2553-2562.
51. Ben-Yoseph O., Boxer P.A., Ross B.D. Assessment of the role of the glutathione and pentose phosphate pathway in the protection of primary cerebrocortical cultures from oxidative stress. J. Neurochem. 66:1996;2329-2337.
52. Dringen R., Hamprecht B., Drukarch B. Anethole dithiolethione, a putative neuroprotectant, increases intracellular and extracellular glutathione levels during starvation of cultured astroglial cells. Naunyn Schmiedebergs Arch. Pharmacol. 358:1998;616-622.
53. Sagara J., Miura K., Bannai S. Maintenance of neuronal glutathione by glial cells. J. Neurochem. 61:1993;1672-1676.
54. Baez S., Linderson Y., Segura-Aguilar J. Superoxide dismutase and catalase prevent the formation of reactive oxygen species during reduction of cyclized dopa ortho-quinone by DT-diaphorase. Chem. Biol. Interact. 93:1994;103-116.
55. Beyer R.E., Segura-Aguilar J., Di Bernados S., Cavazzoni M., Fato R., Fiorentini D., Galli M.C., Setti M., Landi L., Lenaz G. The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc. Natl. Acad. Sci. USA. 93:1996;2528-2532.
56. Siegel D., Bolton E.M., Burr J.A., Liebler D.C., Ross D. The reduction of α-tocopherolquinone by human NAD(P)H:quinone oxidoreductase the role of α-tocopherolhydroquinone as a cellular antioxidant . Mol. Pharmacol. 52:1997;300-305.
57. Drukarch B., van Muiswinkel F.L. Drug treatment of Parkinson's disease time for phase II . Biochem. Pharmacol. 59:2000;1023-1031.
58. Hirsch E.C., Hunot S., Damier P., Faucheux B., Michel P.P., Ruberg M., Muriel M.P., Mouatt-Prigent A., Agid Y. Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease. Adv. Neurol. 80:1999;9-18.